Centiva Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Centiva Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,000	Closed	-$11.5M	–	2256
2026 Q1	$11.5M	Buy	90,000 +40,000	+80%	+$4.99M	0.08%	162
2025 Q4	$6.1M	Hold	50,000	–	–	0.05%	233
2025 Q3	$5.01M	Buy	+50,000	New	+$4.5M	0.05%	227
2025 Q1	–	Sell	-18,300	Closed	-$1.65M	–	2209
2024 Q4	$1.65M	Buy	18,300 +3,900	+27%	+$378K	0.03%	403
2024 Q3	$1.42M	Sell	14,400 -4,900	-25%	-$481K	0.03%	638
2024 Q2	$1.79M	Buy	19,300 +16,100	+503%	+$1.44M	0.03%	477
2024 Q1	$304K	Sell	3,200 -16,600	-84%	-$1.54M	0.01%	1240
2023 Q4	$1.77M	Buy	19,800 +7,300	+58%	+$542K	0.04%	393
2023 Q3	$913K	Sell	12,500 -25,000	-67%	-$2M	0.02%	684
2023 Q2	$3.12M	Buy	37,500 +27,500	+275%	+$2.3M	0.07%	274
2023 Q1	$762K	Buy	+10,000	New	+$830K	0.02%	690
2022 Q3	–	Sell	-25,000	Closed	-$1.86M	–	1840
2022 Q2	$1.86M	Buy	+25,000	New	+$1.88M	0.04%	378
2021 Q1	–	Sell	-4,700	Closed	-$662K	–	1451
2020 Q4	$662K	Hold	4,700	–	–	0.03%	375
2020 Q3	$524K	Hold	4,700	–	–	0.03%	321
2020 Q2	$526K	Sell	4,700 -5,100	-52%	-$502K	0.03%	277
2020 Q1	$759K	Hold	9,800	–	–	0.03%	260
2019 Q4	$933K	Buy	+9,800	New	+$848K	0.05%	297

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Centiva Capital's XBI Position: Q2 2026 in Review

Centiva Capital opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 208 shares worth $32.9K. The stake represents ﹤0.01% of the portfolio and ranks #1660 among its holdings. This is a return to the name: Centiva Capital previously reported a position in XBI as recently as Q2 2024.

Centiva Capital first reported a position in XBI in Q1 2019 and has held it in 8 quarters since. The position peaked at $4.81M in Q4 2023. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Centiva Capital held 208 shares of State Street SPDR S&P Biotech ETF worth $32.9K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Centiva Capital position in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1660 holding.
Centiva Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 8 quarters since.
Centiva Capital's State Street SPDR S&P Biotech ETF position peaked at $4.81M in Q4 2023.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.